You are here

  • Home
  • Archive
  • Volume 75, Issue Suppl 2
  • FRI0225 Short Course of Tocilizumab Increases Risk of Hepatitis B Virus (HBV) Reactivation in Patients with Rheumatoid Arthritis: A Real-World, Prospective Cohort Study

Alerts

Article menu
Download PDFPDF
Poster Presentations
Rheumatoid arthritis - other biologic treatment
FRI0225 Short Course of Tocilizumab Increases Risk of Hepatitis B Virus (HBV) Reactivation in Patients with Rheumatoid Arthritis: A Real-World, Prospective Cohort Study
You need to be signed in to access email alerts. If you have an account log in with your user name and password. If you don't have an account you can just enter your email address in the email box below.
Sign In to Email Alerts with your Email Address